Efficacy and compliance of vulvovaginal candidiasis therapy during pregnancy
<b>Efficacy and compliance of vulvovaginal candidiasis therapy during pregnancy</b><br> Tyutyunnik V.L., Khan N.E., Lomova N.A., Kokoeva D.N.<br> <br> National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov, M...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LCC «Medicine-Inform»
2018-02-01
|
| Series: | РМЖ. Мать и дитя |
| Online Access: | http://wchjournal.com/upload/iblock/8fa/8faea17193a155187b02ecebada20a55.pdf |
| Summary: | <b>Efficacy and compliance of vulvovaginal candidiasis therapy during pregnancy</b><br>
Tyutyunnik V.L., Khan N.E., Lomova N.A., Kokoeva D.N.<br>
<br>
National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov, Moscow<br>
<br>
Vulvovaginal candidiasis is an inflammatory change in the vaginal mucosa caused by a fungal infection due to a significant weakening of the immune system. Vulvovaginal candidiasis occupies one of the leading places among infectious pathologies of the lower segment of the genital tract. A significant prevalence of this pathology is proved by the fact that almost 75% of women experience at least one episode of candidal infection during their lifetime, and in 45% of cases it becomes a disease. Vulvovaginal candidiasis is recorded in 60% of pregnant women. It is more often diagnosed in the first and third trimester, when the hormonal and immune systems undergo significant changes.<br>
Recently, the complex preparation Primafungin<sup>®</sup> has been widely and effectively used from the second trimester of pregnancy. A prospective, randomized blind study of 60 pregnant women with vulvovaginal candidiasis established a reliable efficacy of Primafungin<sup>®</sup>, confirmed by the positive dynamics of clinical signs and laboratory results.<br>
The use of natamycin–containing drugs in the therapy of vulvovaginal candidiasis during pregnancy is highly effective and has no side effects.<br>
<br>
<b>Key words:</b> vulvovaginal candidiasis, pregnancy, therapy, natamycin.<br>
<b>For citation:</b> Tyutyunnik V.L., Khan N.E., Lomova N.A., Kokoeva D.N. Efficacy and compliance of vulvovaginal candidiasis therapy during pregnancy // RMJ. 2018. № 2(I). P. 54–58.<br> |
|---|---|
| ISSN: | 2618-8430 2686-7184 |